Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOPINAVIR for Hepatitis viral: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where LOPINAVIR was used for Hepatitis viral.

Most Reported Side Effects for LOPINAVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 244 19.7% 73 44
Exposure during pregnancy 184 14.8% 22 26
Virologic failure 170 13.7% 7 3
Drug resistance 134 10.8% 9 3
Off label use 133 10.7% 41 70
Lipodystrophy acquired 126 10.1% 1 1
Premature baby 107 8.6% 28 13
Diplopia 89 7.2% 0 4
Treatment failure 89 7.2% 1 1
Premature delivery 88 7.1% 1 5
Eyelid ptosis 87 7.0% 0 0
Mitochondrial toxicity 82 6.6% 0 0
Viral mutation identified 76 6.1% 0 0
Progressive external ophthalmoplegia 73 5.9% 0 0
Pathogen resistance 54 4.4% 0 3

Other Indications for LOPINAVIR

Hiv infection (706) Covid-19 (108) Prophylaxis against hiv infection (96) Product used for unknown indication (68) Antiretroviral therapy (47) Antiviral treatment (34) Foetal exposure during pregnancy (16) Perinatal hiv infection (10) Covid-19 pneumonia (9) Hiv infection who clinical stage iii (9)

Other Drugs Used for Hepatitis viral

SOFOSBUVIR\VELPATASVIR (99) GLECAPREVIR\PIBRENTASVIR (62) ENTECAVIR (42) LEDIPASVIR\SOFOSBUVIR (41) TENOFOVIR ALAFENAMIDE (38) RIBAVIRIN (25) LAMIVUDINE (21) TENOFOVIR DISOPROXIL (21) ELBASVIR\GRAZOPREVIR (20) PEGINTERFERON ALFA-2A (19)

Related Pages

LOPINAVIR Full Profile All Hepatitis viral Drugs LOPINAVIR Demographics LOPINAVIR Timeline